$NYC
American Strategic Investment Co. Stock $nyc

$nyc Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000159552724000006 Filed on April 01, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$15.48M	$15.38M	$62.71M
YoY Change	-0.34%	-5.04%	-2.02%
Cost Of Revenue	$10.29M	$10.16M	$41.48M
YoY Change	-0.19%	4.05%	1.14%
Gross Profit	$5.196M	$5.222M	$21.23M
YoY Change	-0.63%	-18.84%	-7.67%
Gross Profit Margin	33.56%	33.96%	33.86%
Selling, General & Admin	$2.855M	$1.975M	$15.24M
YoY Change	-46.94%	-51.77%	-28.38%
% of Gross Profit	54.95%	37.82%	71.77%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$5.261M	$6.332M	$26.53M
YoY Change	-24.32%	-17.8%	-7.44%
% of Gross Profit	101.25%	121.26%	124.96%
Operating Expenses	$8.116M	$8.307M	$41.77M
YoY Change	-34.19%	-29.59%	-16.36%
Operating Profit	-$2.920M	-$3.085M	-$20.54M
YoY Change	-58.9%	-42.49%	-23.78%
Interest Expense	$4.697M	-$4.749M	-$18.86M
YoY Change	0.73%	-0.04%	-199.65%
% of Operating Profit
Other Income/Expense, Net	-$4.688M	$9.000K	$36.00K
YoY Change	0.73%	50.0%	-100.19%
Pretax Income	-$7.608M	-$73.88M	-$105.9M
YoY Change	-35.3%	630.8%	130.79%
Income Tax	$0.00		$0.00
% Of Pretax Income
Net Earnings	-$7.608M	-$73.88M	-$105.9M
YoY Change	-35.3%	630.8%	130.79%
Net Earnings / Revenue	-49.14%	-480.38%	-168.91%
Basic Earnings Per Share	-$3.28		-$47.57
Diluted Earnings Per Share	-$3.28	-$32.26	-$47.57
COMMON SHARES
Basic Shares Outstanding	2.405M shares	2.334M shares	2.227M shares
Diluted Shares Outstanding	2.323M shares		2.227M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.293M	$5.292M	$5.292M
YoY Change	-39.53%	-42.57%	-42.57%
Cash & Equivalents	$5.293M	$5.292M	$5.292M
Short-Term Investments
Other Short-Term Assets	$5.908M	$6.150M	$6.150M
YoY Change	-2.86%	9.35%	9.35%
Inventory
Prepaid Expenses
Receivables	$30.78M	$30.75M	$30.75M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$41.98M	$42.19M	$42.19M
YoY Change	-4.93%	-4.01%	-4.01%
LONG-TERM ASSETS
Property, Plant & Equipment	$630.3M	$634.9M	$634.9M
YoY Change	-12.79%	-12.8%	-12.8%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$17.52M	$16.67M	$16.67M
YoY Change	-3.74%	-0.69%	-0.69%
Total Long-Term Assets	$647.8M	$652.0M	$652.0M
YoY Change	-12.71%	-12.66%	-12.66%
TOTAL ASSETS
Total Short-Term Assets	$41.98M	$42.19M	$42.19M
Total Long-Term Assets	$647.8M	$652.0M	$652.0M
Total Assets	$689.8M	$694.2M	$694.2M
YoY Change	-12.27%	-12.18%	-12.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$15.49M	$12.98M	$12.98M
YoY Change	18.11%	1.47%	1.47%
Accrued Expenses	$54.64M	$54.66M	$54.66M
YoY Change	-0.11%	-0.11%	-0.11%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due		$49.50M	$49.50M
YoY Change
Total Short-Term Liabilities	$70.13M	$117.1M	$117.1M
YoY Change	3.41%	73.52%	73.52%
LONG-TERM LIABILITIES
Long-Term Debt	$396.1M	$346.2M	$346.2M
YoY Change	0.39%	-12.17%	-12.17%
Other Long-Term Liabilities	$6.215M	$6.044M	$6.044M
YoY Change	-19.98%	-16.25%	-16.25%
Total Long-Term Liabilities	$402.3M	$352.2M	$352.2M
YoY Change	0.0%	-12.24%	-12.24%
TOTAL LIABILITIES
Total Short-Term Liabilities	$70.13M	$117.1M	$117.1M
Total Long-Term Liabilities	$402.3M	$352.2M	$352.2M
Total Liabilities	$472.4M	$469.4M	$469.4M
YoY Change	0.49%	0.11%	-4.09%
SHAREHOLDERS EQUITY
Retained Earnings	-$512.9M	-$505.3M
YoY Change	24.76%	26.52%
Common Stock	$24.00K	$23.00K
YoY Change	4.35%	21.05%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$217.4M	$224.8M	$224.8M
YoY Change
Total Liabilities & Shareholders Equity	$689.8M	$694.2M	$694.2M
YoY Change	-12.27%	-12.18%	-12.18%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$7.608M	-$73.88M	-$105.9M
YoY Change	-35.3%	630.8%	130.79%
Depreciation, Depletion And Amortization	$5.261M	$6.332M	$26.53M
YoY Change	-24.32%	-17.8%	-7.44%
Cash From Operating Activities	$1.655M	-$3.475M	-$7.405M
YoY Change	-323.05%	-9.13%	1423.66%
INVESTING ACTIVITIES
Capital Expenditures	$364.0K	$849.0K	$4.059M
YoY Change	-84.23%	23.04%	-26.93%
Acquisitions
YoY Change
Other Investing Activities		$4.130M	$4.130M
YoY Change
Cash From Investing Activities	-$364.0K	$3.281M	$71.00K
YoY Change	-84.23%	-575.51%	-101.28%
FINANCING ACTIVITIES
Cash Dividend Paid			$0.00
YoY Change			-100.0%
Common Stock Issuance & Retirement, Net			$4.035M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$0.00	-5.000K	4.025M
YoY Change	-100.0%		-164.19%
NET CHANGE
Cash From Operating Activities	$1.655M	-3.475M	-7.405M
Cash From Investing Activities	-$364.0K	3.281M	71.00K
Cash From Financing Activities	$0.00	-5.000K	4.025M
Net Change In Cash	$1.291M	-199.0K	-3.309M
YoY Change	31.07%	-95.59%	-73.12%
FREE CASH FLOW
Cash From Operating Activities	$1.655M	-$3.475M	-$7.405M
Capital Expenditures	$364.0K	$849.0K	$4.059M
Free Cash Flow	$1.291M	-$4.324M	-$11.46M
YoY Change	-142.33%	-4.21%	89.77%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-39448
CY2023	dei	Entity Registrant Name EntityRegistrantName	American Strategic Investment Co.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-4380248
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	11300000	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2404639	shares
CY2022	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.60
CY2022	us-gaap	Dividends Dividends	2670000	usd
CY2022	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	80000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-45896000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	3190000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	321576000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-45896000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-39466000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	28666000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	31057000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1543000	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1543000	usd
CY2022	nycr	Accretionand Amortizationof Belowand Above Market Lease Intangible Assetsand Liabilities AccretionandAmortizationofBelowandAboveMarketLeaseIntangibleAssetsandLiabilities	8000	usd
CY2021	nycr	Accretionand Amortizationof Belowand Above Market Lease Intangible Assetsand Liabilities AccretionandAmortizationofBelowandAboveMarketLeaseIntangibleAssetsandLiabilities	8671000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	8782000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	8475000	usd
CY2022	nycr	Management Fees Reinvested ManagementFeesReinvested	5013000	usd
CY2021	nycr	Management Fees Reinvested ManagementFeesReinvested	0	usd
CY2022	nycr	Common Stock Issued To Directors In Lieu Of Cash For Board Fees CommonStockIssuedToDirectorsInLieuOfCashForBoardFees	62000	usd
CY2021	nycr	Common Stock Issued To Directors In Lieu Of Cash For Board Fees CommonStockIssuedToDirectorsInLieuOfCashForBoardFees	0	usd
CY2022	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2022	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	0	usd
CY2021	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	-79000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5555000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3375000	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	5500000	usd
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	usd
CY2022	nycr	Proceeds From Issuance Of Common Stock Affiliated Entity ProceedsFromIssuanceOfCommonStockAffiliatedEntity	1980000	usd
CY2021	nycr	Proceeds From Issuance Of Common Stock Affiliated Entity ProceedsFromIssuanceOfCommonStockAffiliatedEntity	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5269000	usd
CY2023	us-gaap	Payments Of Dividends PaymentsOfDividends	0	usd
CY2023	nycr	Payment For Redemption Of Stock PaymentForRedemptionOfStock	24000	usd
CY2023	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16117000	usd
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	500000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12800000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16100000	usd
CY2023Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	12200000	usd
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	15500000	usd
CY2023	us-gaap	Interest Expense InterestExpense	18858000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	36000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-27000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-18822000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-18951000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-19043000	usd
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1622896	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1622896	shares
CY2021	us-gaap	Profit Loss ProfitLoss	-39466000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1851000	usd
CY2021	nycr	Payment For Redemption Of Stock PaymentForRedemptionOfStock	0	usd
CY2022	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	80000	usd
CY2021	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	160000	usd
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	10000	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	39994000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9375000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12493000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	26532000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	28666000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	31057000	usd
CY2023	us-gaap	Costs And Expenses CostsAndExpenses	149812000	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	90950000	usd
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	90605000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-26945000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-20386000	usd
CY2021	us-gaap	Interest Expense InterestExpense	19090000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-45896000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-39466000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16117000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28428000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11674000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	7516000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	6902000	usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001595527
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	City Area Code CityAreaCode	212
CY2023	dei	Local Phone Number LocalPhoneNumber	415-6500
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	222 Bellevue Ave.
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Newport
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	RI
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	02840
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	238
CY2023	dei	Auditor Name AuditorName	PricewaterhouseCoopers LLP
CY2023	dei	Auditor Location AuditorLocation	New York, New York
CY2023Q4	us-gaap	Land Land	188935000	usd
CY2022Q4	us-gaap	Land Land	192600000	usd
CY2023Q4	nycr	Buildings Fixturesand Improvements BuildingsFixturesandImprovements	479265000	usd
CY2022Q4	nycr	Buildings Fixturesand Improvements BuildingsFixturesandImprovements	576686000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Asset Acquired In Place Leases FiniteLivedIntangibleAssetAcquiredInPlaceLeases	56929000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Asset Acquired In Place Leases FiniteLivedIntangibleAssetAcquiredInPlaceLeases	71848000	usd
CY2023Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	725129000	usd
CY2022Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	841134000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	144956000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	167978000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	580173000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	673156000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5292000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9215000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	7516000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	6902000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	54737000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	54954000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	6150000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	5624000	usd
CY2023Q4	us-gaap	Derivative Assets DerivativeAssets	400000	usd
CY2022Q4	us-gaap	Derivative Assets DerivativeAssets	1607000	usd
CY2023Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	30752000	usd
CY2022Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	29116000	usd
CY2023Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	9152000	usd
CY2022Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	9881000	usd
CY2023Q4	us-gaap	Assets Assets	694172000	usd
CY2022Q4	us-gaap	Assets Assets	790455000	usd
CY2023Q4	nycr	Secured Debt Netof Deferred Financing Costs SecuredDebtNetofDeferredFinancingCosts	395702000	usd
CY2022Q4	nycr	Secured Debt Netof Deferred Financing Costs SecuredDebtNetofDeferredFinancingCosts	394159000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	12975000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	12787000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	54657000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	54716000	usd
CY2023Q4	us-gaap	Below Market Lease Net BelowMarketLeaseNet	2061000	usd
CY2022Q4	us-gaap	Below Market Lease Net BelowMarketLeaseNet	3006000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	3983000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4211000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	469378000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	468879000	usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-47.57
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-47.57
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2334340	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2334340	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1886298	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1886298	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	23000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	19000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	729644000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	698761000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	406000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1637000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-505279000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-399355000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	224794000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	301062000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	0	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	20514000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	224794000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	321576000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	694172000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	790455000	usd
CY2023	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	62710000	usd
CY2022	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	64005000	usd
CY2021	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	70219000	usd
CY2023	nycr	Asset And Property Management Fees To Related Parties AssetAndPropertyManagementFeesToRelatedParties	7680000	usd
CY2022	nycr	Asset And Property Management Fees To Related Parties AssetAndPropertyManagementFeesToRelatedParties	7082000	usd
CY2021	nycr	Asset And Property Management Fees To Related Parties AssetAndPropertyManagementFeesToRelatedParties	7554000	usd
CY2023	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	33797000	usd
CY2022	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	33927000	usd
CY2021	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	33363000	usd
CY2023	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	66565000	usd
CY2022	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	5863000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	8782000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	8475000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8704000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-87102000	usd
CY2022	us-gaap	Interest Expense InterestExpense	18924000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	47000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-105924000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-45896000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-39429000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	37000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-105924000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	-1231000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	3190000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	1851000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-42706000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-37615000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-26.59
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-26.59
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	381567000	usd
CY2021	nycr	Stock Issued During Period Value New Issues Affiliated Entity StockIssuedDuringPeriodValueNewIssuesAffiliatedEntity	4252000	usd
CY2021	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	183000	usd
CY2021	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	0	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	8476000	usd
CY2021	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	3.20
CY2021	us-gaap	Dividends Dividends	5201000	usd
CY2021	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	160000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	351136000	usd
CY2022	nycr	Stock Issued During Period Value New Issues Affiliated Entity StockIssuedDuringPeriodValueNewIssuesAffiliatedEntity	1980000	usd
CY2022	nycr	Stock Issued During Period Value Issued For Management Fees StockIssuedDuringPeriodValueIssuedForManagementFees	5013000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	8782000	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	121000	usd
CY2023	nycr	Stock Issued During Period Value Warrants And Rights StockIssuedDuringPeriodValueWarrantsAndRights	4059000	usd
CY2023	nycr	Stock Issued During Period Value Issued For Management Fees StockIssuedDuringPeriodValueIssuedForManagementFees	485000	usd
CY2023	nycr	Stock Redeemed During Period Value StockRedeemedDuringPeriodValue	24000	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	5863000	usd
CY2023	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-10000	usd
CY2023	nycr	Adjustments To Additional Paid In Capital Forfeiture Of Performance Units By Noncontrolling Interests Holders AdjustmentsToAdditionalPaidInCapitalForfeitureOfPerformanceUnitsByNoncontrollingInterestsHolders	0	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-105924000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1231000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	224794000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-105924000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	26532000	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1543000	usd
CY2023	nycr	Accretionand Amortizationof Belowand Above Market Lease Intangible Assetsand Liabilities AccretionandAmortizationofBelowandAboveMarketLeaseIntangibleAssetsandLiabilities	70000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	5863000	usd
CY2023	nycr	Management Fees Reinvested ManagementFeesReinvested	485000	usd
CY2023	nycr	Common Stock Issued To Directors In Lieu Of Cash For Board Fees CommonStockIssuedToDirectorsInLieuOfCashForBoardFees	0	usd
CY2023	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	66565000	usd
CY2023	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	0	usd
CY2023	us-gaap	Increase Decrease In Leasing Receivables IncreaseDecreaseInLeasingReceivables	1635000	usd
CY2022	us-gaap	Increase Decrease In Leasing Receivables IncreaseDecreaseInLeasingReceivables	3274000	usd
CY2021	us-gaap	Increase Decrease In Leasing Receivables IncreaseDecreaseInLeasingReceivables	3788000	usd
CY2023	nycr	Increase Decrease In Straight Line Rent Payable IncreaseDecreaseInStraightLineRentPayable	109000	usd
CY2022	nycr	Increase Decrease In Straight Line Rent Payable IncreaseDecreaseInStraightLineRentPayable	110000	usd
CY2021	nycr	Increase Decrease In Straight Line Rent Payable IncreaseDecreaseInStraightLineRentPayable	109000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1516000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1490000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-843000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	871000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3935000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-111000	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-228000	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-909000	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	562000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7405000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-486000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7916000	usd
CY2023	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	4059000	usd
CY2022	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	5555000	usd
CY2021	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	3375000	usd
CY2023	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	4130000	usd
CY2022	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	0	usd
CY2021	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	71000	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	usd
CY2023	nycr	Proceeds From Issuance Of Common Stock Affiliated Entity ProceedsFromIssuanceOfCommonStockAffiliatedEntity	0	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2023	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	4059000	usd
CY2022	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	usd
CY2022	us-gaap	Payments Of Dividends PaymentsOfDividends	2670000	usd
CY2021	us-gaap	Payments Of Dividends PaymentsOfDividends	5201000	usd
CY2022	nycr	Payment For Redemption Of Stock PaymentForRedemptionOfStock	0	usd
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	183000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4025000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6270000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-275000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3309000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-12311000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-11566000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28428000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12808000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5292000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9215000	usd
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	16754000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12808000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16117000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28428000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	17277000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	17396000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	17552000	usd
CY2023	nycr	Stock Issued For Services StockIssuedForServices	0	usd
CY2022	nycr	Stock Issued For Services StockIssuedForServices	121000	usd
CY2021	nycr	Stock Issued For Services StockIssuedForServices	0	usd
CY2023	us-gaap	Stock Issued1 StockIssued1	485000	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	5013000	usd
CY2021	us-gaap	Stock Issued1 StockIssued1	0	usd
CY2023	nycr	Noncashor Part Noncash Accrued Capital Expenditures NoncashorPartNoncashAccruedCapitalExpenditures	-683000	usd
CY2022	nycr	Noncashor Part Noncash Accrued Capital Expenditures NoncashorPartNoncashAccruedCapitalExpenditures	780000	usd
CY2021	nycr	Noncashor Part Noncash Accrued Capital Expenditures NoncashorPartNoncashAccruedCapitalExpenditures	1326000	usd
CY2023	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	0	usd
CY2022	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	0	usd
CY2021	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	1017000	usd
CY2023Q4	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	7	property
CY2023Q4	us-gaap	Net Rentable Area NetRentableArea	1200000	sqft
CY2023Q1	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.125
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Thereafter LessorOperatingLeasePaymentsToBeReceivedThereafter	175276000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	401850000	usd
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	100000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Management makes significant estimates regarding revenue recognition, purchase price allocations to record investments in real estate, and fair value measurements, as applicable.</span></div>
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200000	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200000	usd
CY2022Q4	us-gaap	Adjustment For Amortization AdjustmentForAmortization	400000	usd
CY2023	us-gaap	Revenue Recognition Leases RevenueRecognitionLeases	<div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s revenues, which are derived primarily from lease contracts, include rents that each tenant pays in accordance with the terms of each lease reported on a straight-line basis over the initial term of the lease. As of December 31, 2023, these leases had a weighted-average remaining lease term of 6.5 years. Because many of the Company’s leases provide for rental increases at specified intervals, straight-line basis accounting requires that the Company record a receivable for, and include in revenue from tenants, unbilled rent receivables that the Company will receive if the tenant makes all rent payments required through the expiration of the initial term of the lease. When the Company acquires a property, the acquisition date is considered to be the commencement date for purposes of this calculation. For new leases after acquisition, the commencement date is considered to be the date the tenant takes control of the space. For lease modifications, the commencement date is considered to be the date the lease modification is executed. The Company defers the revenue related to lease payments received from tenants in advance of their due dates. Pursuant to certain of the Company’s lease agreements, tenants are required to reimburse the Company for certain property operating expenses (recorded in total revenue from tenants), in addition to paying base rent, whereas under certain other lease agreements, the tenants are directly responsible for all operating costs of the respective properties. To the extent such costs exceed the applicable tenant’s base year, many but not all of the Company’s leases require the tenant to pay its allocable share of increases in operating expenses, which may include common area maintenance costs, real estate taxes and insurance. Under ASC 842, the Company has elected to report combined lease and non-lease components in a single line “Revenue from tenants.” For expenses paid directly by the tenant, under both ASC 842 and 840, the Company has reflected them on a net basis.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company owns certain properties with leases that include provisions for the tenant to pay contingent rental income based on a percent of the tenant’s sales upon the achievement of certain sales thresholds or other targets which may be monthly, quarterly or annual targets. As the lessor under the aforementioned leases, the Company defers the recognition of contingent rental income, until the specified target that triggered the contingent rental income is achieved, or until such sales upon which percentage rent is based are known. For the years ended December 31, 2023, 2022 and 2021, approximately $0.1 million, $0.5 million and $0.5 million, respectively, in contingent rental income is included in revenue from tenants in the consolidated statements of operations and comprehensive loss.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continually reviews receivables related to rent and unbilled rents receivable and determines collectability by taking into consideration the tenant’s payment history, the financial condition of the tenant, business conditions in the industry in which the tenant operates and economic conditions in the area in which the property is located. Under the leasing standard adopted on January 1, 2019, the Company is required to assess, based on credit risk, if it is probable that the Company will collect virtually all of the lease payments at the lease commencement date, and it must continue to reassess collectability periodically thereafter based on new facts and circumstances affecting the credit risk of the tenant. Partial reserves, or the ability to assume partial recovery are no longer permitted. If the Company determines that it is probable that it will collect virtually all of the lease payments (base rent and additional rent), the lease will continue to be accounted for on an accrual basis (i.e., straight-line). However, if the Company determines it is not probable that it will collect virtually all of the lease payments, the lease will be accounted for on a cash basis and the straight-line rent receivable accrued will be written off, as well as any accounts receivable, where it was subsequently concluded that collection was not probable. Cost recoveries from tenants are included in operating revenue from tenants, in accordance with current accounting rules, on the accompanying consolidated statements of operations and comprehensive loss in the period the related costs are incurred, as applicable.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with lease accounting rules the Company records uncollectable amounts as reductions in revenue from tenants. Some of these reductions may relate to tenants that terminated their leases early or relate to leases that had not been paying rent and were been placed on a cash basis in accordance with ASC 842. There were no such reductions recorded for the years ended 2023 or 2022. During the year ended December 31, 2022 there was only one tenant for which we recorded rent on a cash basis. The lease with this tenant was terminated as of September 30, 2022. During the years ended 2023 and 2021, no rental income was received from any of the tenants that were previously placed on a cash basis.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the Company signed a termination agreement with the parking garage tenants at its 400 E. 67th Street - Laurel Condominium/200 Riverside Boulevard properties. As discussed above, new tenants have signed lease agreements with the Company for the spaces in July 2022. In addition, the Company recorded a termination fee for a tenant in its 9 Times Square property. These termination agreements required the tenants to pay termination fees aggregating $1.5 million to the Company, which was all received during the fourth quarter of 2021. The termination fees are recorded in revenue from tenants in the consolidated statements of operations and comprehensive loss.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2021, the Company launched Innovate NYC, a co-working company, at 1140 Avenue of the Americas. The Company recorded revenue of approximately </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$0.7 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$0.8 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $0.3 million from Innovate NYC during the years ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2023, 2022 and 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively, which is considered non-lease income. In November of 2023 Innovate NYC terminated its agreement with the Company. In December of 2023, subsequent to Innovate NYC’s termination, the Company released its space in its entirety to a new tenant and will be recording rental income on that space per the terms of the lease.</span></div>
CY2023	nycr	Lessor Operating Lease Weighted Average Remaining Lease Term LessorOperatingLeaseWeightedAverageRemainingLeaseTerm	P6Y6M
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	56205000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	49064000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	44112000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	40733000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Five Years LessorOperatingLeasePaymentsToBeReceivedFiveYears	36460000	usd
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	500000	usd
CY2022	nycr	Number Of Tenants With Rent Recorded On Cash Basis NumberOfTenantsWithRentRecordedOnCashBasis	1	tenant
CY2021	nycr	Rental Income Tenants Previously Placed On Cash Basis RentalIncomeTenantsPreviouslyPlacedOnCashBasis	0	usd
CY2023	nycr	Rental Income Tenants Previously Placed On Cash Basis RentalIncomeTenantsPreviouslyPlacedOnCashBasis	0	usd
CY2021Q4	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	1500000	usd
CY2023	us-gaap	Other Operating Income OtherOperatingIncome	700000	usd
CY2022	us-gaap	Other Operating Income OtherOperatingIncome	800000	usd
CY2021	us-gaap	Other Operating Income OtherOperatingIncome	300000	usd
CY2021	nycr	Number Of Acquisitions During Period NumberOfAcquisitionsDuringPeriod	0	acquisition
CY2023	nycr	Number Of Acquisitions During Period NumberOfAcquisitionsDuringPeriod	0	acquisition
CY2022	nycr	Number Of Acquisitions During Period NumberOfAcquisitionsDuringPeriod	0	acquisition
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1908000	usd
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2023	us-gaap	Derivatives Reporting Of Derivative Activity DerivativesReportingOfDerivativeActivity	<div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Instruments</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may use derivative financial instruments to hedge all or a portion of the interest rate risk associated with its borrowings. Several of the techniques used to hedge exposure to interest rate fluctuations may also be used to protect against declines in the market value of assets that result from general trends in debt markets. The principal objective of such agreements is to minimize the risks and costs associated with the Company’s operating and financial structure as well as to hedge specific anticipated transactions.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records all derivatives on the balance sheet at fair value. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Derivatives designated and qualifying as a hedge of the exposure to changes in the fair value of an asset, liability, or firm commitment attributable to a particular risk, such as interest rate risk, are considered fair value hedges. Derivatives designated and qualifying as a hedge of the exposure to variability in expected future cash flows, or other types of forecasted transactions, are considered cash flow hedges. Derivatives may also be designated as hedges of the foreign currency exposure of a net investment in a foreign operation. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accounting for subsequent changes in the fair value of these derivatives depends on whether each has been designated and qualifies for hedge accounting treatment. If the Company elects not to apply hedge accounting treatment, any change in the fair value of these derivative instruments is recognized immediately in gains (losses) on derivative instruments in the accompanying consolidated statements of operations and comprehensive loss. If the derivative is designated and qualifies for hedge accounting treatment, the change in the estimated fair value of the derivative is recorded in other comprehensive income (loss) to the extent that it is effective with any ineffective portion of a derivative’s change in fair value will be immediately recognized in earnings. After the adoption of ASU 2017-12, if the derivative qualified for hedge accounting, all the change in value is recorded in other comprehensive income.</span></div>
CY2023	nycr	Number Of Properties With Recorded Impairment NumberOfPropertiesWithRecordedImpairment	2	property
CY2021	nycr	Number Of Properties With Recorded Impairment NumberOfPropertiesWithRecordedImpairment	1	property
CY2022	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	56929000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	26704000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	30225000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	71848000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	36511000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	35337000	usd
CY2023Q4	us-gaap	Below Market Lease Gross BelowMarketLeaseGross	9628000	usd
CY2023Q4	us-gaap	Below Market Lease Accumulated Amortization BelowMarketLeaseAccumulatedAmortization	7567000	usd
CY2023Q4	us-gaap	Below Market Lease Net BelowMarketLeaseNet	2061000	usd
CY2022Q4	us-gaap	Below Market Lease Gross BelowMarketLeaseGross	10718000	usd
CY2022Q4	us-gaap	Below Market Lease Accumulated Amortization BelowMarketLeaseAccumulatedAmortization	7712000	usd
CY2022Q4	us-gaap	Below Market Lease Net BelowMarketLeaseNet	3006000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2967000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1340000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1332000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1292000	usd
CY2023Q4	nycr	Amortization Income Net Next Twelve Months AmortizationIncomeNetNextTwelveMonths	438000	usd
CY2023Q4	nycr	Amortization Income Net Year Two AmortizationIncomeNetYearTwo	380000	usd
CY2023Q4	nycr	Amortization Income Net Year Three AmortizationIncomeNetYearThree	66000	usd
CY2023Q4	nycr	Amortization Income Net Year Four AmortizationIncomeNetYearFour	63000	usd
CY2023Q4	nycr	Amortization Income Net Year Five AmortizationIncomeNetYearFive	68000	usd
CY2023Q4	us-gaap	Debt Instrument Collateral Amount DebtInstrumentCollateralAmount	752600000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	49500000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	99000000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	140000000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	60000000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	51000000	usd
CY2023Q4	us-gaap	Secured Debt SecuredDebt	399500000	usd
CY2022Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	3400000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12800000	usd
CY2023Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	6094000	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	400000	usd
CY2023Q4	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	usd
CY2023Q4	us-gaap	Derivative Asset Collateral Obligation To Return Cash Offset DerivativeAssetCollateralObligationToReturnCashOffset	0	usd
CY2023Q4	us-gaap	Derivative Assets DerivativeAssets	400000	usd
CY2023Q4	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	0	usd
CY2023Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	0	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral	400000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	1607000	usd
CY2022Q4	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	usd
CY2022Q4	us-gaap	Derivative Asset Collateral Obligation To Return Cash Offset DerivativeAssetCollateralObligationToReturnCashOffset	0	usd
CY2022Q4	us-gaap	Derivative Assets DerivativeAssets	1607000	usd
CY2022Q4	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	0	usd
CY2022Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	0	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral	1607000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	0	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	0	usd
CY2021Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	1700000	usd
CY2021Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	1700000	usd
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2300000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1900000	shares
CY2020Q3	nycr	Distribution Reinvestment Plan Termination Notice Period DistributionReinvestmentPlanTerminationNoticePeriod	P10D
CY2022	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.60
CY2021	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	3.20
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P43Y
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.086
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	54700000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	54700000	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	4700000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	4700000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	4700000	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	4900000	usd
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	4900000	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	4900000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	4746000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	4746000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	4746000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	4746000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	4746000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	188262000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	211992000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	157335000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	54657000	usd
CY2023	nycr	Advisory Agreement Renewal Term AdvisoryAgreementRenewalTerm	P5Y
CY2018Q4	nycr	Period Prior To Expiration Date Needed To Terminate Agreement PeriodPriorToExpirationDateNeededToTerminateAgreement	P180D
CY2022Q3	nycr	Series And Overall Limit Percentage SeriesAndOverallLimitPercentage	0.06
CY2023	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	12032000	usd
CY2022	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	11457000	usd
CY2021	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	11618000	usd
CY2023Q4	nycr	Common Stock Shares Authorized For Grant Percentage CommonStockSharesAuthorizedForGrantPercentage	0.200
CY2021	nycr	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Fractional Share Redemption ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsFractionalShareRedemption	1	shares
CY2021	nycr	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Fractional Share Redemption Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsFractionalShareRedemptionWeightedAverageGrantDateFairValue	78.48
CY2020Q3	nycr	Share Based Compensation Arrangement By Share Based Payment Award Number Of Trading Days Following The List Date ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfTradingDaysFollowingTheListDate	30	d
CY2020Q3	nycr	Equity Based Compensation Consecutive Trading Days EquityBasedCompensationConsecutiveTradingDays	10	trading_day
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5300000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8400000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8400000	usd
CY2023	nycr	Distributions On The Ltip Unit DistributionsOnTheLTIPUnit	0.10
CY2023	nycr	Distribution On The Earned Ltip Unit DistributionOnTheEarnedLTIPUnit	0.90
CY2023	nycr	Number Subjects To Awards That Reduce Shares Available Ratio NumberSubjectsToAwardsThatReduceSharesAvailableRatio	1	shares
CY2023	nycr	Sharebased Compensation Arrangementby Sharebased Payment Award Shares Issuedin Period In Lieu Of Cash SharebasedCompensationArrangementbySharebasedPaymentAwardSharesIssuedinPeriodInLieuOfCash	0	shares
CY2021	nycr	Sharebased Compensation Arrangementby Sharebased Payment Award Shares Issuedin Period In Lieu Of Cash SharebasedCompensationArrangementbySharebasedPaymentAwardSharesIssuedinPeriodInLieuOfCash	0	shares
CY2023	nycr	Income Tax Expense Capital Base Tax IncomeTaxExpenseCapitalBaseTax	400000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	37000	usd
CY2023Q4	nycr	Uncertain Tax Positions UncertainTaxPositions	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	47688000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	23008000	usd
CY2023Q4	nycr	Deferred Tax Assets Deferred Leasing Costs DeferredTaxAssetsDeferredLeasingCosts	1360000	usd
CY2022Q4	nycr	Deferred Tax Assets Deferred Leasing Costs DeferredTaxAssetsDeferredLeasingCosts	1145000	usd
CY2023Q4	nycr	Deferred Tax Assets Restricted Stock Awards And2020 Opp DeferredTaxAssetsRestrictedStockAwardsAnd2020OPP	71000	usd
CY2022Q4	nycr	Deferred Tax Assets Restricted Stock Awards And2020 Opp DeferredTaxAssetsRestrictedStockAwardsAnd2020OPP	6458000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	1246000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	1317000	usd
CY2023Q4	nycr	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	17091000	usd
CY2022Q4	nycr	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	17110000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	49477000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	53613000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	135000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	129000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	117068000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	102780000	usd
CY2023Q4	nycr	Deferred Tax Liabilities Straight Line Rent DeferredTaxLiabilitiesStraightLineRent	9616000	usd
CY2022Q4	nycr	Deferred Tax Liabilities Straight Line Rent DeferredTaxLiabilitiesStraightLineRent	9105000	usd
CY2023Q4	nycr	Deferred Tax Liabilities Operating Leases Right To Use Assets DeferredTaxLiabilitiesOperatingLeasesRightToUseAssets	17116000	usd
CY2022Q4	nycr	Deferred Tax Liabilities Operating Leases Right To Use Assets DeferredTaxLiabilitiesOperatingLeasesRightToUseAssets	17184000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	26732000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	26289000	usd
CY2023Q4	nycr	Deferred Tax Asset Before Valuation Allowance Net DeferredTaxAssetBeforeValuationAllowanceNet	90336000	usd
CY2022Q4	nycr	Deferred Tax Asset Before Valuation Allowance Net DeferredTaxAssetBeforeValuationAllowanceNet	76491000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	90336000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	76491000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	1
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-105924000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-45896000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-39466000	usd
CY2023	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2022	us-gaap	Dilutive Securities DilutiveSecurities	-80000	usd
CY2021	us-gaap	Dilutive Securities DilutiveSecurities	-160000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-105924000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-45976000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-39626000	usd
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2226721	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2226721	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1729264	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1729264	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1622896	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1622896	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-47.57
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-47.57
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-26.59
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-26.59
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-24.42
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-24.42
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	343811	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	515296	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	504481	shares
CY2023Q4	srt	Real Estate And Accumulated Depreciation Amount Of Encumbrances RealEstateAndAccumulatedDepreciationAmountOfEncumbrances	399500000	usd
CY2023Q4	us-gaap	Real Estate And Accumulated Depreciation Initial Cost Of Land RealEstateAndAccumulatedDepreciationInitialCostOfLand	188935000	usd
CY2023Q4	us-gaap	Real Estate And Accumulated Depreciation Initial Cost Of Buildings And Improvements RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements	502779000	usd
CY2023Q4	us-gaap	Sec Schedule Iii Real Estate And Accumulated Depreciation Costs Capitalized Subsequent To Acquisition Buildings And Improvements SECScheduleIIIRealEstateAndAccumulatedDepreciationCostsCapitalizedSubsequentToAcquisitionBuildingsAndImprovements	-23514000	usd
CY2023Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	668200000	usd
CY2023Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	118252000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Asset Acquired In Place Leases FiniteLivedIntangibleAssetAcquiredInPlaceLeases	56900000	usd
CY2023Q4	srt	Real Estate Federal Income Tax Basis RealEstateFederalIncomeTaxBasis	730600000	usd
CY2023Q4	nycr	Finite Lived Intangible Assetsand Liabilities Accumulated Amortization FiniteLivedIntangibleAssetsandLiabilitiesAccumulatedAmortization	26700000	usd
CY2022Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	769286000	usd
CY2021Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	765176000	usd
CY2020Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	762519000	usd
CY2023	us-gaap	Real Estate Improvements RealEstateImprovements	3376000	usd
CY2022	us-gaap	Real Estate Improvements RealEstateImprovements	6335000	usd
CY2021	us-gaap	Real Estate Improvements RealEstateImprovements	4701000	usd
CY2023	us-gaap	Real Estate Cost Of Real Estate Sold RealEstateCostOfRealEstateSold	4524000	usd
CY2022	us-gaap	Real Estate Cost Of Real Estate Sold RealEstateCostOfRealEstateSold	0	usd
CY2021	us-gaap	Real Estate Cost Of Real Estate Sold RealEstateCostOfRealEstateSold	0	usd
CY2023	us-gaap	Sec Schedule Iii Real Estate Writedown Or Reserve Amount SECScheduleIIIRealEstateWritedownOrReserveAmount	66320000	usd
CY2022	us-gaap	Sec Schedule Iii Real Estate Writedown Or Reserve Amount SECScheduleIIIRealEstateWritedownOrReserveAmount	0	usd
CY2021	us-gaap	Sec Schedule Iii Real Estate Writedown Or Reserve Amount SECScheduleIIIRealEstateWritedownOrReserveAmount	1452000	usd
CY2023	us-gaap	Real Estate Other Deductions RealEstateOtherDeductions	33618000	usd
CY2022	us-gaap	Real Estate Other Deductions RealEstateOtherDeductions	2225000	usd
CY2021	us-gaap	Real Estate Other Deductions RealEstateOtherDeductions	592000	usd
CY2023Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	668200000	usd
CY2022Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	769286000	usd
CY2021Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	765176000	usd
CY2022Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	131467000	usd
CY2021Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	112641000	usd
CY2020Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	92470000	usd
CY2023	us-gaap	Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense	20796000	usd
CY2022	us-gaap	Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense	21051000	usd
CY2021	us-gaap	Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense	20684000	usd
CY2023	us-gaap	Real Estate Accumulated Depreciation Real Estate Sold RealEstateAccumulatedDepreciationRealEstateSold	393000	usd
CY2022	us-gaap	Real Estate Accumulated Depreciation Real Estate Sold RealEstateAccumulatedDepreciationRealEstateSold	0	usd
CY2021	us-gaap	Real Estate Accumulated Depreciation Real Estate Sold RealEstateAccumulatedDepreciationRealEstateSold	0	usd
CY2023	us-gaap	Real Estate Accumulated Depreciation Other Deductions RealEstateAccumulatedDepreciationOtherDeductions	33618000	usd
CY2022	us-gaap	Real Estate Accumulated Depreciation Other Deductions RealEstateAccumulatedDepreciationOtherDeductions	2225000	usd
CY2021	us-gaap	Real Estate Accumulated Depreciation Other Deductions RealEstateAccumulatedDepreciationOtherDeductions	513000	usd
CY2023Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	118252000	usd
CY2022Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	131467000	usd
CY2021Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	112641000	usd

Files In Submission

Name	View Source	Status
0001595527-24-000006-index-headers.html	Edgar Link	pending
0001595527-24-000006-index.html	Edgar Link	pending
0001595527-24-000006.txt	Edgar Link	pending
0001595527-24-000006-xbrl.zip	Edgar Link	pending
ex1047secondamendmentto2nd.htm	Edgar Link	pending
ex1048thirdamendmenttoprop.htm	Edgar Link	pending
ex211subsidiarylist123123.htm	Edgar Link	pending
ex231pwcconsent123123.htm	Edgar Link	pending
ex311ceocertification123123.htm	Edgar Link	pending
ex312cfocertification123123.htm	Edgar Link	pending
ex32ceoandcfocertification.htm	Edgar Link	pending
ex44nycr-descriptionofsecu.htm	Edgar Link	pending
ex97.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nycr-20231231.htm	Edgar Link	pending
nycr-20231231.xsd	Edgar Link	pending
nycr-20231231_g1.jpg	Edgar Link	pending
nycr-20231231_g2.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
nycr-20231231_cal.xml	Edgar Link	unprocessable
nycr-20231231_def.xml	Edgar Link	unprocessable
nycr-20231231_pre.xml	Edgar Link	unprocessable
nycr-20231231_htm.xml	Edgar Link	completed
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
nycr-20231231_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NYC
American Strategic Investment Co. Stock $nyc

2024 Q1 Form 10-K Financial Statement

#000159552724000006 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NYC American Strategic Investment Co. Stock $nyc

2024 Q1 Form 10-K Financial Statement

#000159552724000006 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NYC
American Strategic Investment Co. Stock $nyc